$2.5 Million to Support the Immunomodulatory Therapy for Down Syndrome Project
Mar 6, 2025 Benefactor Spotlight Gift Announcement Office of Advancement Patient Care Research & InnovationDr. Espinosa and his collaborators are paving the way for the first immunomodulatory therapy for children with Down syndrome, which could launch a new age of treatments to improve the quality of life and extend the lifespan of millions of individuals living with this condition.